WHAT DOES THIS HAVE A SOURCE FOR ASIE?
The effect will be felt especially in Asia. India ( 26 % ), Indonesia ( 10 % ), China ( 68 % ), the Philippines ( 68 % ), and Pakistan ( 66.3 % ) make up the top five high-burden TB nations, which account for more than half of all cases worldwide.
The US supports Tuberculosis control initiatives in Cambodia, Indonesia, Myanmar, Philippines, Vietnam, Bangladesh, India, and Pakistan in various ways. Some of these nations ‘ local TB control costs are overfunded by USAID and the Global Fund combined.
As World Health Organization Director-General Dr. Tedros Adhanom Ghebreyesus warned on March 17 that their and another lower- and middle-income nations are “facing catastrophic failures in their]TB response,” given their heavy reliance on US international aid.
Nine nations have previously reported that their anti-TB supply stores are failing. As health employees are laid off, treatment prices fall, and the source of anti-TB medications frequently drops, the number of cases and incidents rises. TB cases that are drug-resistant may also rise drastically.
These nations are unable to easily make up for the cash shortfall by reallocating funds from other health initiatives like those that the US frequently supports and are also facing related budget cuts, such as HIV, dengue, childhood vaccination, and nutrition. These health interests are now being made by institutions.